<?xml version="1.0" encoding="UTF-8"?>
<ref id="b10-1031654">
 <label>10.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Luger</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Perl</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Kemner</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase I dose escalation study of the mTOR inhibitor sirolimus and MEC chemotherapy targetting signal transduction in leukemic stem cells for acute myeloid leukemia</article-title>. 
  <source>Blood</source>. 
  <year>2006</year>;
  <volume>108</volume>(
  <issue>11</issue>):
  <fpage>161</fpage>.
 </mixed-citation>
</ref>
